We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Rock Regulatory News (GCG)

  • This share is currently suspended. It was suspended at a price of 3.05

Share Price Information for Golden Rock (GCG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.05
GCG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interims for Period Ending 30 June 2018

17 Sep 2018 10:26

RNS Number : 9650A
Golden Rock Global PLC
17 September 2018
 

 

 

 

 

 

 

 

 

 

 

 

 

Golden Rock Global plc

(Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 with registered number 121560)

 

Unaudited Condensed Interim

Financial Statements

 

For the Period from 1st January 2018

to 30 June 2018

 

 

 

 

 

 

 

CHAIRMAN'S STATEMENT

 

It is a pleasure to announce the interim results for the Company which cover the six month period to 30 June 2018.

 

The net loss in the period was £135,995 (30 June 2017: (£187,000). The Board remains mindful of preserving shareholder funds and I'm pleased to report that as at 30 June 2018 cash balances totalled £773,172 (31 December 2017 £960,858).

 

During the period the Board has continued its search for a suitable acquisition but notes that the number of opportunities it has received has recently slowed down. In light of this the Board has arranged for its acquisition criteria to be circulated to a database of professional advisers and it is hopeful that this will generate an increased supply of potential opportunities over the coming months.

 

Whilst it is taking longer than originally anticipated to find a suitable acquisition the Board's view remains that the fintech sector is a global phenomenon that is still gathering strength and that a suitable opportunity that satisfy's the Company's investment creteria will be identified. It is therefore the intention to continue to pursue the Company's current strategy.

 

In the Prospetus dated 25 October 2016, the Board agreed to consult with Shareholders on the ongoing direction and activities of the Company if a suitable acquisition had not been completed within two years and as such I would like to Shareholders to write me, at the registered office of the Company, with their views by the end of October 2018.

 

The Company intends to announce the result of the Shareholder consultation later this year.

 

 

On behalf of the Board I thank shareholders for their continued support.

 

 

 

 

Ross Andrews

 

Chairman

 

Date: 17/09/2018

 

 

 

 

 

STATEMENT OF DIRECTORS' RESPONSIBILITIES

 

The directors confirm, to the best of their knowledge, that these condensed interim financial statements have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely:

· An indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

· Material related party transactions in the first six months and any material changes in the related party transactions described in the last Annual Report and Accounts.

The directors of Golden Rock Global plc are listed in the Golden Rock Global plc Annual Report and Accounts 2017. A list of current directors is maintained on the website:

http://www.grg.london/

 

 

 

 

 

By Order of the Board

 

 

 

 

Wei Chen

Director

 

Date: 17/09/2018

 

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

 

Note

 

Half Year to 30/06/2018

Unaudited

£

 

 

Half Year to 30/06/2017

Unaudited

£

 

Revenue

 

-

 

-

Administrative expenses

 

(136,036.00)

 

(187,082.00)

Operating loss

 

(136,036.00)

 

(187,082.00)

 

 

 

 

 

Finance income

 

41.00

 

61.00

Loss before taxation

 

(135,995.00)

 

(187,021.00)

Taxation

9

-

 

-

Total comprehensive loss attributable to equity holders of the Company for the period

 

 

(135,995.00)

 

 

(187,021.00)

 

 

 

 

 

 

 

 

Loss per share - basic and diluted (pence per share)

 

10

0.85

1.17

          

 

The notes on pages 7 to 13 form an integral part of these financial statements.

 

 

CONDENSED STATEMENT OF FINANCIAL POSITION

As at 30 June 2018

 

 

 

 

 

 

Note

 

30/06/2018

Unaudited

£

 

 

31/12/2017

 

£

 

Assets

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Prepayments and other receivables

 

 

3,898.00

 

 

24,775.00

 

Cash and cash equivalents

11

 

773,172.00

 

 

960,858.00

 

Total current assets

 

 

777,070.00

 

 

985,633.00

 

Total assets

 

 

777,070.00

 

 

985,633.00

 

 

Equity and liabilities

 

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

 

 

Ordinary shares

13

 

160,000.00

 

 

160,000.00

 

Share premium

13

 

1,439,100.00

 

 

1,439,100.00

 

Accumulated losses

 

 

(842,161.00)

 

 

(706,167.00)

 

Total equity

 

 

756,939.00

 

 

892,933.00

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Accruals

 

 

20,131.00

 

 

 75,875.00

 

Amounts due to shareholders

12

 

-

 

 

16,825.00

 

Total current liabilities

 

 

20,131.00

 

 

92,700.00

 

 

 

 

 

 

 

 

 

Total equity and liabilities

 

 

756,939.00

 

 

985,633.00

 

 

 

 

 

 

 

These financial statements were approval by the Board of Directors for issue on __17/09/2018________ and signed on behalf by:

 

 

 

 

WEI CHEN

Executive Director

 

 

The notes on pages 7 to 13 form an integral part of these financial statements.

 

              

 

  

CONDENSED STATEMENT OF CHANGES IN EQUITY

 

FOR THE PERIOD ENDED 30 JUNE 2018

 

 

 

 

 

 

 

 

 

 

Note

Share

capital

Share premium

 

Accumulated losses

 

 

Total equity

 

 

 

£

£

 

£

 

 

£

 

 

 

 

 

Balance at 1 January 2018 13

160,000

1,439,100

 

(706,167)

 

 

892,933

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss for the financial period

 

 

 

-

 

-

 

 

(135,994)

 

 

 

(135,994)

 

Balance at 30 June 2018 (Unaudited)

160,000

1,439,100

 

(842,161)

 

 

756,939

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FOR THE PERIOD ENDED 30 JUNE 2017

 

 

 

 

 

 

 

 

 

 

 

Note

Share

capital

Share premium

 

Accumulated losses

 

 

Total equity

 

 

 

£

£

 

£

 

 

£

 

 

 

 

 

 

 

 

 

 

Balance at 01 January 2017  13

160,000

1,439,100

 

(340,322)

 

 

1,258,778

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive profit for the financial period

 

 

 

-

 

-

 

 

(187,021)

 

 

 

(187,021)

 

Balance at 30 June 2017 (Unaudited)

160,000

1,439,100

 

(527,343)

 

 

1,071,757

 

 

 

The notes on pages 7 to 13 form an integral part of these financial statements.

 

                

 

 

 

 

 

CONDENSED STATEMENT OF CASH FLOWS

 

 

 

 

 

 

Half Year to 30/06/2018

Unaudited

£

 

 

Half Year to 30/06/2017

Unaudited

£

 

Cash flows from operating activities

 

 

 

 

 

Operating loss

 

(136,036)

 

(187,082)

 

Foreign exchange gain

 

2,364

 

(67,916)

 

Decrease in receivables

 

20,878

 

1,118

 

Decrease in payables

 

(55,744)

 

(1,678)

 

Net cash used in operating activities

 

(168,538)

 

(255,558)

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Interest received

 

41

 

61

 

Net cash generated from investing activities

 

41

 

61

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Proceeds from issue of ordinary shares

 

-

 

-

 

Proceeds from borrowings

 

-

 

4,628

 

Repayment of borrowings

 

(16,825)

 

(144,781)

 

Net cash generated from financing activities

 

(16,825)

 

(140,153)

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

 

 

 

Cash and cash equivalents at beginning of the half-year

 

960,858

 

1,454,083

 

Foreign exchange movement

 

(2,364)

 

67,916

 

Cash and cash equivalents at end of the half-year

 

 

773,172

 

 

1,126,349

 

 

 

 

 

 

The notes on pages 7 to 13 form an integral part of these financial statements.

 

         

 

 

 

 

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

1. GENERAL INFORMATION

The Company was incorporated and registered in Jersey as a public company limited by shares on 17 June 2016 under the Companies (Jersey) Law 1991, as amended, with the name Golden Rock Global plc, and registered number 121560.

The Company's registered office is located at 11 Bath Street, St Helier, JE2 4ST, Jersey.

2. PRINCIPAL ACTIVITIES

The principal activity of the Company is to seek acquisition opportunities, initially focusing on the Fintech sector.

3. RECENT ACCOUNTING PRONOUNCEMENT

a) New interpretations and revised standards effective for the period ended 30 June 2018

The Company has adopted the new interpretations and revised standards effective for the year ended 31 December 2017. The adoption of these interpretations and revised standards had no material impact on the disclosures and presentation of the financial statements.

b) Standards and interpretations in issue but not yet effective

 

A number of new standards and amendments to existing standards have been issued, but are not effective for the period ended 30 June 2018. The Directors do not anticipate that the adoption of these revised standards and interpretations will have a significant impact on the figures included in the financial statements in the period of initial application other than the following:

 

Amendments to IFRS 9: Financial Instruments

 

This amendment confirm that when a financial liability measured at amortised cost is modified without this resulting in de-recognition, a gain or loss should be recognised immediately in profit or loss.

 

The gain or loss is calculated as the difference between the original contractual cash flows and the modified cash flows discounted at the original effective interest rate. This means that the difference cannot be spread over the remaining life of the instrument which may be a change in practice from IAS 39.

 

The standard is effective for periods beginning on or after 1 January 2019.

 

 

 

 

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

4. ACCOUNTING POLICIES

a) Basis of preparation

The condensed interim financial statements for the six months ended 30 June 2018 were approved by the Board of Directors on 17 September 2018. The condensed interim financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and International Accounting Standard 34 "Interim Financial Reporting" (IAS 34) as adopted by the European Union. The accounting policies applied by the company in these condensed interim financial statements are the same as those set out in the company's Annual Report and Accounts for the year ended 31 December 2017. No material new standards, amendments to standards or interpretations are effective in the period ending 30 June 2018.

 

The condensed interim financial statements are unaudited and have not been reviewed by the auditors. The financial information for the year ended 31 December 2017 does not constitute the Company's statutory financial statements. The Company's statutory financial statements for that year have been filed with the Jersey Registrar of Companies and received an unqualified auditor's report.

 

The condensed interim financial statements have been prepared on the going concern basis which assumes that the company will continue in operational existence for the foreseeable future on the grounds that the Director will continue to financially support the company until such time has the business achieves financial viability. The company financial statements do not reflect any adjustments that would be required if they were to be prepared on a basis other than the going concern basis.

 

The financial information is presented in Pounds Sterling (£), which is the Company's functional and presentational currency.

 

b) Foreign currency translation

The financial statements of the Company are presented in the currency of the primary environment in which the Company operates (its functional currency).

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit and loss.

c) Financial instruments

Financial assets and financial liabilities are recognised in the Statement of Financial Position when the Company becomes a party to the contractual provisions of the instruments. Financial assets and financial liabilities are initially measured at fair value.

Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition.

Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognised immediately in profit or loss.

 

 

 

 

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

4. ACCOUNTING POLICIES (CONT'D)

Impairment of financial assets

An assessment for impairment is undertaken when there is objective evidence that a financial asset is impaired. Impairment loss on financial assets is recognised when there is objective evidence that the Company will not be able to collect all the amounts due to it in accordance with the original terms of the receivables. The amount of the impairment loss is determined as the difference between the asset's carrying amount and the present value of estimated future cash flows.

Financial liabilities

The Company's financial liabilities include amounts due to shareholders and other payables and accruals. Financial liabilities are recognised when the Company becomes a party to the contractual provision of the

instrument. All financial liabilities are recognised initially at their fair value, net of transaction costs, and subsequently measured at amortised cost, using the effective interest method, unless the effect of discounting would be insignificant, in which case they are stated at cost.

The Company derecognises financial liabilities when, and only when, the Company's obligations are discharged, cancelled or they expire.

 

d) Cash and cash equivalents

Cash and cash equivalents includes cash in hand, deposits held on call with banks and other short term (having maturity within 3 months) highly liquid investments that are readily convertible into known amounts of cash and which are subject to an insignificant risk of changes in value.

e) Earnings per share

Basic earnings per share is computed using the weighted average number of shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of shares during the period plus the dilutive effect of dilutive potential ordinary shares outstanding during the year.

 

5. ACCOUNTING ESTIMATES AND JUDGEMENTS

Preparation of financial information in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources.

It is the Directors' view that there are no significant areas of estimation, uncertainty and critical judgements in applying accounting policies that have significant effect on the amount recognised in the financial information for the period.

 

  

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

 

6. FINANCIAL RISK MANAGEMENT

a) Categories of financial instruments

The carrying amounts and fare value of the Company's financial assets and liabilities as at the end of the reporting year are as follows:

 

 

 

Half Year to 30/06/2018

 

Half Year to 30/06/2017

 

 

 

£

 

£

 

Financial assets

 

 

 

 

 

Loans and receivables (including cash and cash equivalents)

 

773,172

 

1,126,349

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

 

Financial liabilities at amortised cost

 

-

 

10,483

 

b) Financial risk management objectives and policies.

 

The Company is exposed to a variety of financial risks: market risk (including interest rate risk and currency risk), credit risk and liquidity risk. The risk management policies employed by the Company to manage these risks are discussed below. The primary objectives of the financial risk management function are to establish risk limits, and then ensure that exposure to risk stays within these limits. The operational and legal risk management functions are intended to ensure proper functioning of internal policies and procedures to minimise operational and legal risks.

i) Interest rate risks

All cash holdings and cash equivalents are held in accounts with variable rates.

ii) Currency risks

The Company is exposed to exchange rate fluctuations as transactions are undertaken denominated in foreign currencies.

At 30 June 2018 the Company had £718,428 cash and cash equivalents in a Hong Kong Dollar account. At 30 June 2018, had the exchange rate between the Pound Sterling and the Hong Kong Dollar increased/decreased by 10%, the effect on the result in the period would be a gain of £65,000/ loss of £65,000.

iii) Credit risk

Credit risk refers to the risk that counterparty will default on its contractual obligations resulting in financial loss to the Company. Credit allowances are made for estimated losses that have been incurred by the reporting date.

Concentrations of credit risk exist to the extent that the Company's cash balances were all held with China Merchants Bank. Per Standard & Poor's, the Short Term Foreign / Local Currency Deposit Rating is A-2.

iv) Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities. The Company's approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company's reputation.

The Company's financial liabilities are primarily amounts due to shareholders. The amounts are unsecured, interest-free and repayable on demand.

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

 

7. SEGMENT REPORTING

 

IFRS 8 defines operating segments as those activities of an entity about which separate financial information is available and which are evaluated by the Board of Directors to assess performance and determine the allocation of resources. The Board of Directors are of the opinion that under IFRS 8 the Company has only one operating segment and one geographic market in UK. The Board of Directors assess the performance of the operating segment using financial information which is measured and presented in a manner consistent with that in the Financial Statements. Segmental reporting will be reviewed and considered in light of the development of the Company's business over the next reporting period.

8. STAFF COSTS AND KEY MANAGEMENT EMOLUMENTS

 

 

Half Year to 30/06/2018

£

 

 

 

 

Half Year to 30/06/2017

£

Key management emoluments

 

 

 

 

 

 

Remuneration

 

50,000

 

 

 

50,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The annual remuneration of the key management was as follows, with no other cash or non-cash benefits.

 

 

 

 

 

 

 

 

 

£

 

 

 

 

Executive Directors

 

 

 

 

 

 

 

 

Wei Chen

 

 

 

7,500

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-executive Directors

 

 

 

 

 

 

 

 

Ross Andrews

 

 

 

15,000

 

 

 

 

John Croft

 

 

 

12,500

 

 

 

 

Feng Chen

 

 

 

7,500

 

 

 

 

Bin Shi

 

 

 

7,500

 

 

 

 

 

 

 

 

50,000

 

 

 

 

                

 

Included within accruals is £15,000, which relates to unpaid directors remuneration.

 

 

 

 

9. TAXATION

The Company is incorporated in Jersey, and its activities are subject to taxation at a rate of 0%.

 

10. EARNINGS PER SHARE

The Company presents basic and diluted earnings per share information for its ordinary shares. Basic earnings per share are calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares in issue during the reporting period. Diluted earnings per share are determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary shares outstanding for the effects of all dilutive potential ordinary shares.

There is no difference between the basic and diluted earnings per share, as the Company has no potential ordinary shares.

 

 

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

 

10. EARNINGS PER SHARE (CONT'D)

 

 

 

Half Year to 30/06/2018

 

Half Year to 30/06/2017

 

 

 

 

 

Loss attributable to ordinary shareholders

 

 

135,995

187,021

Weighted average number of shares

 

 

16,000,000

16,000,000

Earnings per share (expressed as pence per share)

 

 

0.85

1.17

 

 

 

 

 

      

11. CASH AND CASH EQUIVALENTS

 

 

30/06/2018

 

31/12/2017

 

 

£

 

 

£

 

Cash at bank equivalents

 

773,172

 

1,126,349

 

 

 

 

 

 

Cash at bank earns interest at floating rates based on daily bank deposit rates.

 

 

 

12. AMOUNTS DUE TO SHAREHOLDERS

 

 

30/06/2018

 

31/12/2017

 

 

£

 

 

£

 

Shareholders' loan

 

-

 

16,825

 

 

 

 

 

          

The shareholders' loan is unsecured, interest free and repayable on demand. The balance has been fully repaid during the period

 

13. SHARE CAPITAL

 

 

Number of shares

Nominal

value

£

 

Authorised

 

 

 

Ordinary shares of GBP 0.01 each

48,000,000

480,000

 

 

 

 

 

Issued and fully paid

 

 

 

On incorporation

100

100

 

Subdivided share capital

9,900

-

 

 

10,000

100

 

Issue of shares upon placing

15,990,000

159,900

 

At 31 December 2017 and 30 June 2018

16,000,000

160,000

 

 

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

 

13. SHARE CAPITAL (CONT'D)

The Company was incorporated and registered in Jersey as a public company limited by shares on 17 June 2016 and was authorised to issue 10,000 shares of £1 each. The total issued shares on incorporation were 100 shares of £1 each.

On 19 October 2016, it was resolved to subdivide the Company's share capital by a ratio of 1:100, so that the shares had a nominal value of £0.01 per share. It was also resolved to increase the authorised share capital from 1,000,000 share of £0.01 each to 48,000,000 shares of £0.01 each.

On 20 October 2016, a total of 15,990,000 ordinary shares of £0.01 each were issued by way of placing with institutional and other investors at a placing price of £0.10 per placing share for cash consideration £1,599,000 on the Main market of the London Stock Exchange. The excess of the placing price over the par value of the shares issued was credited to the share premium account.

The issued shares have nominal value of each share of £0.01 and are fully paid. There are no restrictions on the distribution of dividends and the repayment of capital.

14. CAPITAL MANAGEMENT

The Company manages its capital to ensure that it will be able to continue as a going concern while maximising the return to shareholders through the optimisation of the balance between debt and equity.

The capital structure of the Company as at 30 June 2018 consisted of equity attributable to the equity holders of the Company, totalling £756,939 (disclosed in the statement of changes in equity).

The Company reviews the capital structure on an on-going basis. As part of this review, the directors consider the cost of capital and the risks associated with each class of capital. The Company will balance its overall capital structure through the payment of dividends, new share issues and the issue of new debt or the repayment of existing debt.

15. RELATED PARTY TRANSACTIONS

The remuneration of the Directors, the key management personnel of the Company, is set out in note 8.

As at 30 June 2018, there is nil balance due to the shareholders (see note 12).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR ZMGMLLNFGRZG
12
Date   Source Headline
13th Dec 202312:54 pmRNSExtension of Debt facility
29th Sep 20237:00 amRNSHalf-year Report
17th Aug 20237:39 amRNSProposed Transaction and Suspension of Listing
17th Aug 20237:30 amRNSSuspension - Golden Rock Global plc
26th Jul 20239:44 amRNSHolding(s) in Company
20th Jul 20234:36 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFundraising and Broker Appointment
19th Jul 20237:00 amRNSUpdate on Potential Acquisition
28th Jun 20237:00 amRNSStmnt re Share Price Movement
12th Jun 20237:00 amRNSResult of AGM
28th Apr 20233:29 pmRNSAnnual Financial Report
5th Apr 20233:11 pmRNSRestoration of Trading
5th Dec 20227:00 amRNSIssue of Debt
18th Oct 20227:00 amRNSHalf-year Report
30th Sep 20223:46 pmRNSResult of AGM
14th Jun 20227:00 amRNSFinal Results
17th Nov 20217:40 amRNSStatement re. Suspension
16th Nov 20214:40 pmRNSSecond Price Monitoring Extn
16th Nov 20214:35 pmRNSPrice Monitoring Extension
16th Nov 20212:05 pmRNSSecond Price Monitoring Extn
16th Nov 20212:00 pmRNSPrice Monitoring Extension
15th Nov 202111:05 amRNSSecond Price Monitoring Extn
15th Nov 202111:00 amRNSPrice Monitoring Extension
12th Nov 20212:27 pmRNSHolding(s) in Company
26th Oct 20214:35 pmRNSHolding(s) in Company
27th Sep 20213:20 pmRNSHalf-year Report
20th Jul 202112:32 pmRNSResult of AGM
18th Jun 202110:30 amRNSNotice of AGM
7th May 20218:35 amRNSFinal Results
15th Apr 20212:06 pmRNSSecond Price Monitoring Extn
15th Apr 20212:01 pmRNSPrice Monitoring Extension
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20212:05 pmRNSSecond Price Monitoring Extn
12th Mar 20212:00 pmRNSPrice Monitoring Extension
12th Mar 202111:06 amRNSSecond Price Monitoring Extn
12th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20214:00 pmRNSUpdate to Fundraising and expected Admission Date
8th Mar 20212:06 pmRNSSecond Price Monitoring Extn
8th Mar 20212:00 pmRNSPrice Monitoring Extension
8th Mar 202111:06 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
5th Mar 20214:40 pmRNSSecond Price Monitoring Extn
5th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20212:05 pmRNSSecond Price Monitoring Extn
5th Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Feb 20214:33 pmRNSFundraising and Board Changes
10th Feb 202111:06 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.